Team for Health Economics, Policy and Technology Assessment
Analysis of large datasets
Extrapolation of event rates
Estimation of treatment effects
Estimating resource use
Evidence synthesis and decision modelling
Blood and Transplant
STIs and HIV
New PhD opportunities
Current RD topics
Recently completed theses
Previous seminars slides
Comments are closed.
European Commission’s Horizon 2020 scheme funds evaluation of ‘Omics’ screen to discriminate between bacterial and viral infection (
NIHR funds work to evaluate alternatives strategies for mainting the supply of blood to the NHS (
presented at Vancouver Health Economics Methodology (VanHEM) meeting 2017. Slides
has an exciting opportunity for
Research Fellow in Health Economics
. Further details
UK Causal Inference meeting 2017
short-course on missing data methods for trial-based CEA
. Full programme
38th Annual North-American Medical Decision Making meeting
LSE Health and Social Care
Tweets by @THETA_lshtm
Recent THETA publications
Cost-effectiveness of risk-based breast cancer screening programme, China.
[Accepted Manuscript] Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women.
A Bayesian framework for health economic evaluation in studies with missing data.
Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
Correction to: Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain.
Strategy of endovascular versus open repair for patients with clinical diagnosis of ruptured abdominal aortic aneurysm: the IMPROVE RCT.
Cost-effectiveness of alternative changes to a national blood collection service.
Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain.
Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial.
Cost-Effectiveness of Take-Home Naloxone for the Prevention of Overdose Fatalities among Heroin Users in the United Kingdom.